INTRODUCTION
Nontuberculous mycobacterial (NTM) infections commonly present as a chronic cervical lymphadenitis in immunocompetent children under the age of 5 years. [1] [2] [3] Typically affecting the levels I and II nodes, these infections begin as slowly enlarging, painless neck masses. Untreated, the infected nodes surface to the skin and erupt. This progression often takes place over several months. 1, 4 The diagnosis is often delayed and made after several failed treatments with antistreptococcal and anti-staphylococcal antibiotics. Atypical mycobacteria, the bacteria responsible for NTM infections, are ubiquitously found in the soil, food, and various animals. 5 More than 50 species of mycobacteria have been described; approximately 50% of these species are pathogenic. 6 Surgical excision through complete resection or curettage is the gold standard for treatment of NTM infections. It has been shown to be associated with low recurrence and little morbidity. 2, 7 In fact, in a recent review by Panesar et al., 7 55 patients with a cervicofacial NTM infection underwent total excision with only one recurrence. However, when these infections were treated only with an incision and drainage, 20 of the 21 patients developed a recurrence. 7 Tunkel 8 and Saggese et al. 9 also noted a low recurrence rate associated with surgical resection and curettage. Therefore, the current surgical recommendation is complete resection of NTM infections by excision or curettage.
The role of medical management remains unclear for NTM infections. Several studies have shown poor responses to anti-tuberculous medications. 3, 10 However, more recent studies using macrolides such as clarithromycin (Braxin) have reported successful treatment with antibiotic therapy alone. [11] [12] [13] [14] Specifically, Harza et al. 13 reported a 50% complete resolution of NTM infection without requiring surgical excision. Berger et al. 14 nitis with Biaxin and rifabutin in eight patients. These have all been small studies involving 10 or fewer patients.
With the emerging data of successful treatment of NTM infections with antimicrobial therapy, our institution has recently trended toward initiating treatment of NTM infections with a trial of medical management. In the present study, we review our experience with NTM infections since 1993, emphasizing the effect of antimicrobial therapy.
PATIENTS AND METHODS
The medical records of all available children under the age of 18 years who were given a diagnosis of NTM cervicofacial lymphadenitis and treated by at least one of the authors from January 1, 1993, to November 1, 2003, were retrospectively reviewed. The criteria for the diagnosis of NTM adenitis was based on a history of chronic cervicofacial lymphadenitis with either a fine-needle aspiration or excisional biopsy that met one or more of the following criteria: 1) lymph node culture positive for an atypical mycobacteria, 2) histological findings consistent with mycobacterial infection (granulomas) with negative bartonella serological titers, 3) histological stain positive for the presence of AFB in the absence of tuberculous infection or 4) positive Mantoux tuberculin skin test with a negative PCR for tuberculous mycobacteria.
Data reported were extracted from review of notes from hospitalizations, laboratory reports, surgery dictations, and clinical notes. Follow-up was obtained by chart review. The present study was approved by the University of Texas Southwestern Medical Center (Dallas, TX) Institutional Review Board for research.
RESULTS
Fifty-five patients were diagnosed with NTM cervicofacial lymphadenitis during the 10-year period. Forty-five of the 55 patients had an initial trial of medical therapy. Patients were retrospectively divided into four groups based on the treatment and response to treatment (Table I) . Group 1 had resolution with antibiotic treatment alone. The antibiotics usually included a macrolide with a possible addition of anti-tuberculous antibiotics or multidrug anti-tubercular therapy (n ϭ 30). The choice of antibiotics was physician dependent. Group 2 was treated with antimicrobials followed by surgical excision (n ϭ 15). Group 3 was treated with surgical excision followed by adjuvant antibiotic therapy (n ϭ 5). Group 4 had only surgical intervention with either total excision or curettage (n ϭ 5). Of the patients who were initially treated with medical therapy, 30 of 45 (67%) had resolution with only antibiotic therapy (Table I) .
Of the patients treated with antibiotics alone, 11 of 30 (37%) had documented improvement within 1 month (Table II) . Given the retrospective nature of the study, not all of the patients had documentation of node size after 1 month of treatment. Of the remaining 19 patients, 12 (63%) showed response to antibiotic treatment by the second month. Ultimately, 77% (23 of 30) of the cases of NTM cervicofacial lymphadenitis in these children had begun to regress by 2 months of treatment. By 6 months, all but one patient (patient 14) (Table III) , had resolution of the lymphadenitis. Patient 14 had four separate nodes within her parotid and submandibular gland that resolved after receiving treatment for 1 year.
Although the medical regimen was not standardized, 22 of the 30 patients were initially started on a regimen of Biaxin, either alone or in combination with an antimycobacterial antibiotic such as ethambutol or rifampin. Within this group, 40% (9 of 22 patients) had documented improvement within the first month. By the second month, 18 of the 22 patients (82%) had responded to the antibiotics (Table II) . Of the 19 patients treated with antibiotics alone who did not respond within the first month of antibiotic therapy, 15 continued with their current therapy and began to respond by the second month. Four patients underwent a change in their therapy regimen (Table III) . All three were initiated with rifampin in combination with either Biaxin (2 of 4) or isoniazid (1 of 4) or both (1 of 4). In summary, 15 of 30 children were started on a regimen of Biaxin alone and 13 of the 15 children responded by 2 months of treatment (Table II) . The other patients responded to therapy involving a combination of drugs. Only one recurrence of infection was noted after antibiotic therapy was stopped. This recurrence was successfully treated with a 1-month treatment with Biaxin (Tables IV). Of the 15 patients who initially received antibiotics followed by surgical excision, 6 patients responded well to 2 months of treatment (Table V) . In these patients, the nodes decreased in size or ceased to enlarge. None of these patients underwent a change in the drug regimen. Despite this positive response to medical therapy, surgical excision or curettage was pursued with ultimate resolution, except in one case. For patient 11 (Table V) , a recurrence was noted after surgical excision. The infection was ultimately resolved with 3-month course of postoperative antibiotics.
Our institution has also had experience with the use of antibiotics as adjuvant therapy to surgical excision (Table I). Five patients initially underwent surgical excision followed by several months of antibiotic therapy. Three of the five patients (60%) had either known multiple lymphadenitis preoperatively or residual lymphadenitis after surgery. The other two patients received postoperative antibiotics for recurrent lymphadenitis (Table IV) . Both were successfully treated with medical therapy alone.
Of the patients who underwent surgical excision initially (groups 3 and 4), 3 of 10 (30%) required additional treatment for recurrence. As described earlier in the present study, two of the recurrences occurred in the group treated initially with surgery. The recurrences were managed medically. The other recurrence was treated with surgical resection with resolution. Table IV lists all four groups and the number of recurrences in each group.
Of the 55 patients, 9 had involvement of the parotid gland. Of these patients, 6 of 9 (67%) of the patient's infections were resolved with antibiotic treatment alone. Two patients' lesions were initially treated with antibiotics with some decrease in lesion size before proceeding with surgical excision. One patient underwent surgical excision but had a recurrence of the infection at the same location. Biaxin was given for 1 month to help reduce the active infection followed by a superficial parotidectomy. No facial nerve paresis was noted in any of the patients.
DISCUSSION
Although surgical excision remains the gold standard for the treatment of NTM infections, the introduction of new antibiotics such as the macrolides present new treatment options. Pharmacological studies on clarithromycin showed good antimicrobial activity against atypical mycobacteria. 15 This first translated clinically into the successful treatment of Mycobacterium avium-intracellulare complex infections in patients with acquired immune deficiency syndrome (AIDS). 16 With the relatively benign pharmacological profile of the macrolides, small case reports eventually emerged revealing successful treatments of Mycobacterium avium-intracellulare complex infections in children. 11,12,14 Lindeboom et al. 12 discussed the treatment of two immunocompetent children with NTM cervicolymphadenitis. The children both underwent a 2-month treatment with a single modality of Biaxin only. The infections began responding within the first month of treatment, with complete resolution noted by 2 months. There were no complications of the treatment. Macrolide treatment was proving to be a possible alternative to surgical excision.
Similar to the pilot studies treating NTM infections with macrolides, our experience suggests that antibiotic therapy can resolve or at least ameliorate NTM infections. Of the 45 patients who were initially treated with antibiotics, 30 patients (67%) had resolution without surgical excision or curettage, a percentage similar to that published by Harza et al. 13 Fifteen of the 45 patients who initially were treated with antibiotics underwent surgical excision for complete resolution of their lymphadenitis. Three categories of these patients were recognized. The first group, which consisted of only 7 patients (47%), showed no response to the antibiotics or continued to have progression of the infection while on a regimen of antibiotics. The second group (2 of 15 patients [13%]) received only a limited trial of antimicrobial therapy consisting of a period of 3 weeks or less. The third group (6 of 15 [40%]) showed some improvement or cessation of disease progression while on a regimen of antibiotics. The third group proceeded to surgery as either the parents' or the surgeons' choice, despite showing improvement. Therefore, even in the third group of patients who seemingly failed antibiotic treatment, a closer evaluation revealed that many responded positively while on a regimen of antibiotics.
The present retrospective review identified several cases in which treatment with antibiotics was a successful adjuvant therapy to surgical excision. In cases in which multiple lymph nodes were involved and not completely removed or in which there was recurrence after surgical intervention, addition of antibiotic treatment can complement surgical excision.
One argument against the benefit of antibiotic therapy is that the resolution of disease while on a regimen of antibiotics may represent the natural history of the infection. For NTM infections, duration of antibiotic treatment ranges from a minimum period of 2 months to a maximum period of 6 months. The studies evaluating the natural history of NTM infections have shown that these infections undergo a predictable progression starting with lymphadenitis. Then, the lymph node surfaces to the skin and erupts, which leads to resolution of the infection. In the present study, antibiotic therapy seemed to interrupt this natural progression in a majority of patients and resulted in minimization of the palpable lymph node and/or prevention of fistulization of the infected nodes.
As with all retrospective studies, the present study has weaknesses in selection and review bias. In addition, we were limited to and dependent on the clinical data that were recorded and available for review. The antibiotic regimen was diverse, making conclusions about specific medical therapies difficult to support definitively. Future prospective studies involving more defined medical regimens and closer follow-up may yield better information on the most appropriate medical management of these infections.
CONCLUSION
Some NTM cervicofacial lymphadenitis infections appear to respond to medical therapy alone. A trial of antibiotic therapy might be considered in patients with NTM 
